AndrewDNordenMD

PubMed

• 2 citations
  ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
  Andrew E Sloan, Charles J Nock, Xiaobu Ye, Robert Buerki, Susan Chang, Glenn Lesser, Andrew Norden, Timothy Cloughesy, Jeffrey Olson, Amber Kerstetter-Fogle, Jeremy Ri...> ;Journal of Neuro-Oncology. 2023 Jan 1
• 4 citations
  Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 rando...
  Sarah E. Nelson, Robert P. Giugliano, Elliott M. Antman, Jeong-Gun Park, Andrew D. Norden, Natalia S. Rost, Scott B. Silverman, Aneesh B. Singhal, Hans Lanz, Eugene Br...> ;Journal of Clinical Neuroscience. 2021 Apr 1
• 2 citations
  Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort
  Elizabeth B Lamont, Andrew Yee, Stuart L. Goldberg, David S. Siegel, Andrew D. Norden> ;JNCI Cancer Spectrum. 2021 Jan 5
• 8 citations
  Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.
  Jorg Dietrich, Laura Versmée, Jan Drappatz, April F. Eichler, Lakshmi Nayak, Andrew D. Norden, Eric T. Wong, Michelle Pisapia, SooAe Jones, Amanda Gordon, Bruce A. Cha...> ;The Oncologist. 2020 Sep 1
• 5 citations
  Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.
  Abdalla Aly, Prianka Singh, Beata Korytowsky, You-Li Ling, Hrishikesh Kale, Homa Dastani, Marc F. Botteman, Andrew D. Norden> ;Neuro-Oncology Practice. 2019 Sep 30
• 22 citations
  Exploring Predictors of Response to Dacomitinib in EGFR -Amplified Recurrent Glioblastoma.
  Andrew S. Chi, Daniel P. Cahill, David A. Reardon, Patrick Y. Wen, Tom Mikkelsen, David M. Peereboom, Eric T. Wong, Elizabeth R. Gerstner, Jorg Dietrich, Scott R. Plot...> ;JCO Precision Oncology. 2020 Jun 8
• 15 citations
  Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer
  Martin Gutierrez, Kristin Price, R.B. Lanman, Rebecca J. Nagy, Irfan Shah, Shivam Mathura, Michael Mulcahy, Andrew D. Norden, Stuart L. Goldberg> ;JCO Precision Oncology. 2019 Dec 6
• 8 citations
  Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.
  Donna M. McNamara, Stuart L. Goldberg, Lisa M. Latts, Deena Graham, Stanley E. Waintraub, Andrew D. Norden, Cody Landstrom, Andrew L. Pecora, John Hervey, Eric V Schul...> ;Cancer Medicine. 2019 Sep 11
• 69 citations
  An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.
  Mark Stewart, Andrew D. Norden, Nancy A Dreyer, Henry J. Henk, Amy P. Abernethy, Elizabeth A. Chrischilles, Lawrence H. Kushi, Aaron S. Mansfield, Sean Khozin, Elad Sh...> ;JCO Clinical Cancer Informatics. 2019 Jul 23
• 11 citations
  A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
  Andrew D. Norden, Beata Korytowsky, Min You, T. Kim Le, Homa Dastani, Sarah Bobiak, Prianka Singh> ;Journal of Managed Care & Specialty Pharmacy. 2019 Mar 27
• 11 citations
  A Patient‐Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Pallia...
  Stuart L. Goldberg, Dhakshila Paramanathan, Raya Khoury, Sharmi Patel, Dayo Jagun, Srikesh Arunajadai, Victoria DeVincenzo, Ruth Pe Benito, Brooke Gruman, Sukhi Kaur, ...> ;The Oncologist. 2019 Jan 1
• 5 citations
  Development of a Precise, Clinically Relevant, Digital Classification Schema for Cancer.
  Andrew L. Pecora, Andrew D. Norden, John Hervey, Eric V Schultz, Thomas L Gallucci, Elizabeth Rushforth, Stuart L. Goldberg> ;JCO Clinical Cancer Informatics. 2018 Oct 16
• 35 citations
  Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.
  Eudocia Q. Lee, Dan G. Duda, Alona Muzikansky, Elizabeth R. Gerstner, John G. Kuhn, David A. Reardon, Lakshmi Nayak, Andrew D. Norden, Lisa Doherty, Debra LaFrankie, J...> ;Clinical Cancer Research. 2018 Oct 1
• 13 citations
  A Descriptive Analysis of End-of-Life Conversations With Long-Term Glioblastoma Survivors.
  Stephen P. Miranda, Rachelle Bernacki, Joanna Paladino, Andrew D. Norden, Jane Kavanagh, Marissa Palmor, Susan D. Block> ;The American Journal of Hospice & Palliative Care. 2018 Apr 29
• 3 citations
  Realizing the Promise of Cognitive Computing in Cancer Care: Ushering in a New Era.
  Andrew D. Norden, Irene Dankwa-Mullan, Alexandra Urman, Fernando Suarez, Kyu Rhee> ;JCO Clinical Cancer Informatics. 2018 Feb 16
• 136 citations
  Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board
  S. P. Somashekhar, Martín-José Sepúlveda, S. Puglielli, Andrew D. Norden, Edward H. Shortliffe, C Rohit Kumar, Amit Rauthan, N.B. Arun kumar, Poonam Patil, Kyu Rhee, Y...> ;Annals of Oncology. 2018 Feb 1
• 16 citations
  Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
  Nils D. Arvold, Diana D. Shi, Ayal A. Aizer, Andrew D. Norden, David A. Reardon, Eudocia Q. Lee, Lakshmi Nayak, Ian F. Dunn, Alexandra J. Golby, Mark D. Johnson, Eliza...> ;Journal of Neuro-Oncology. 2017 Oct 3
• 10 citations
  Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients.
  Shan Jiang, Kala Hill, Dipen Patel, A. Reginald Waldeck, Marc F. Botteman, Abdalla Aly, Andrew D. Norden> ;Journal of Medical Economics. 2017 Aug 16
• 76 citations
  Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next...
  Natalia S. Rost, Robert P. Giugliano, Christian T. Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew D. Norden, Scott Silverman, Aneesh B. Singhal, Jose C. Nicolau, B...> ;Stroke. 2016 Aug 1
• 70 citations
  Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study
  Jorge J. Castillo, Shirley D'Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García-Sanz, Lak...> ;British Journal of Haematology. 2016 Mar 1
• 126 citations
  Extent of resection and overall survival for patients with atypical and malignant meningioma
  Ayal A. Aizer, Wenya Linda Bi, Manjinder Singh Kandola, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Rameen Beroukhim, David A. Reardon, Patrick Y...> ;Cancer. 2015 Dec 15
• 86 citations
  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy
  Terri S. Armstrong, Robin Grant, Mark R. Gilbert, Jong Woo Lee, Andrew D. Norden> ;Neuro-Oncology. 2016 Jun 1
• 40 citations
  Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
  Shakti Ramkissoon, Wenya Linda Bi, Steven E. Schumacher, Lori A. Ramkissoon, Sam Haidar, David S. Knoff, Adrian M. Dubuc, Loreal Brown, Margot Burns, Jane Cryan, Malak...> ;Neuro-Oncology. 2015 Oct 1
• 19 citations
  Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningiomaAuthor Response
  Marc C. Chamberlain, Patrick Y. Wen, Andrew D. Norden> ;Neurology. 2015 Sep 22
• 63 citations
  A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma
  Ayal A. Aizer, Malak Abedalthagafi, Wenya Linda Bi, M.C. Horvath, Nils D. Arvold, Ossama Al-Mefty, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Da...> ;Neuro-Oncology. 2015 Aug 30
• Join now to see all

Abstracts/Posters

• The Unforeseen Medical and Business Challenges Found When Integrating Abstracted Data from Disparate EHR Systems While Building the Curecloud Direct-to-Patient Multipl...
  Andrew D Norden, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma
  Andrew D Norden, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Treatment patterns and outcomes among t(11;14) myeloma patients in a real-world setting. 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Other

• Secondary involvement of the central nervous system by non-Hodgkin lymphoma 
  Norden AD, Hochberg E, Hochberg FH
  http://www.uptodate.com/contents/secondary-involvement-of-the-central-nervous-system-by-non-hodgkin-
  UpToDate, Wolters Kluwer Health - 2012-11-26
• Uncommon brain tumors 
  Norden AD, Chheda MG, Wen PY
  http://www.uptodate.com/contents/uncommon-brain-tumors
  UpToDate, Wolters Kluwer Health - 2013-02-28